Full Text
EE837 Cost Effectiveness of Nirsevimab and Maternal RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Disease Among Infants in the United States

Abstract

Authors

X Liu T Yu W Padula

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×